Monashee Investment Management
Latest statistics and disclosures from Monashee Investment Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are IVV, VOO, VEA, IEFA, VWO, and represent 50.34% of Monashee Investment Management's stock portfolio.
- Added to shares of these 10 stocks: BUD (+$16M), SN (+$15M), KSPI (+$11M), AHR (+$9.9M), ODD (+$8.9M), GE (+$8.4M), SLDB (+$8.3M), BBB Foods (+$7.7M), GTES (+$7.6M), NDAQ (+$6.6M).
- Started 80 new stock positions in RGLS, NVDA, OLMA, ALIT, NAMSW, Morgan Stanley Direct Le, KSPI, GEHC, CRGY, Auna S A.
- Reduced shares in these 10 stocks: , VEA, GPCR, ARGX, LVS, IEFA, KRRO, Ambrx Biopharma, SWTX, PR.
- Sold out of its positions in ANTX, ARGX, AURA, BLUE, ETNB, FLNC, HCI, KPTI, KVYO, LVS. MYGN, Ambrx Biopharma, PCG, PR, PCT, STTK, SWTX, SEAT, WVE.
- Monashee Investment Management was a net buyer of stock by $234M.
- Monashee Investment Management has $845M in assets under management (AUM), dropping by 49.20%.
- Central Index Key (CIK): 0001627608
Tip: Access up to 7 years of quarterly data
Positions held by Monashee Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelPortfolio Holdings for Monashee Investment Management
Monashee Investment Management holds 105 positions in its portfolio as reported in the March 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Ishares Tr Core S&p500 Etf (IVV) | 15.4 | $130M | 247k | 525.73 |
|
|
Vanguard Index Fds S&p 500 Etf Shs (VOO) | 15.3 | $129M | 269k | 480.70 |
|
|
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA) | 8.7 | $74M | -5% | 1.5M | 50.17 |
|
Ishares Tr Core Msci Eafe (IEFA) | 6.5 | $55M | -5% | 736k | 74.22 |
|
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO) | 4.5 | $38M | -3% | 913k | 41.77 |
|
Ishares Core Msci Emkt (IEMG) | 3.9 | $33M | -2% | 646k | 51.60 |
|
Ishares Tr Core S&p Ttl Stk (ITOT) | 2.9 | $24M | -2% | 211k | 115.30 |
|
Vanguard Index Fds Total Stk Mkt (VTI) | 2.9 | $24M | -2% | 94k | 259.90 |
|
Anheuser Busch Inbev Sa Sponsored Adr (BUD) | 1.9 | $16M | NEW | 270k | 60.78 |
|
Sharkninja Com Shs (SN) | 1.8 | $15M | NEW | 238k | 62.29 |
|
Aercap Holdings Nv SHS (AER) | 1.4 | $12M | +55% | 140k | 86.91 |
|
Kaspi Kz Jsc Sponsored Ads (KSPI) | 1.3 | $11M | NEW | 87k | 128.64 |
|
American Healthcare Reit Com Shs (AHR) | 1.2 | $9.9M | NEW | 670k | 14.75 |
|
Oddity Tech Shs Cl A (ODD) | 1.1 | $8.9M | NEW | 205k | 43.45 |
|
General Electric Com New (GE) | 1.0 | $8.4M | NEW | 48k | 175.53 |
|
Solid Biosciences Com New (SLDB) | 1.0 | $8.3M | NEW | 620k | 13.32 |
|
Bbb Foods Cl A Com | 0.9 | $7.7M | NEW | 323k | 23.78 |
|
Gates Indl Corp Ord Shs (GTES) | 0.9 | $7.6M | NEW | 430k | 17.71 |
|
Vaxcyte (PCVX) | 0.8 | $6.8M | +166% | 100k | 68.31 |
|
Nasdaq Omx (NDAQ) | 0.8 | $6.6M | NEW | 105k | 63.10 |
|
Viper Energy Cl A (VNOM) | 0.8 | $6.3M | NEW | 165k | 38.46 |
|
Super Micro Computer (SMCI) | 0.7 | $6.1M | NEW | 6.0k | 1010.03 |
|
Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.7 | $5.8M | NEW | 115k | 50.23 |
|
Werewolf Therapeutics (HOWL) | 0.7 | $5.8M | NEW | 890k | 6.48 |
|
Corebridge Finl (CRBG) | 0.7 | $5.7M | +166% | 200k | 28.73 |
|
Rev (REVG) | 0.7 | $5.7M | NEW | 259k | 22.09 |
|
Cg Oncology | 0.6 | $5.5M | NEW | 125k | 43.90 |
|
Kinetik Holdings Com New Cl A (KNTK) | 0.6 | $5.0M | +92% | 125k | 39.87 |
|
Korro Bio (KRRO) | 0.6 | $5.0M | -39% | 55k | 90.00 |
|
RadNet (RDNT) | 0.6 | $4.9M | NEW | 100k | 48.66 |
|
Dyne Therapeutics (DYN) | 0.6 | $4.8M | NEW | 170k | 28.39 |
|
Ichor Holdings SHS (ICHR) | 0.6 | $4.7M | NEW | 123k | 38.62 |
|
Symbotic Class A Com (SYM) | 0.6 | $4.7M | NEW | 105k | 45.00 |
|
Aquestive Therapeutics (AQST) | 0.5 | $4.3M | NEW | 1.0M | 4.26 |
|
Gossamer Bio (GOSS) | 0.5 | $4.1M | 3.5M | 1.18 |
|
|
Structure Therapeutics Sponsored Ads (GPCR) | 0.5 | $4.1M | -50% | 95k | 42.86 |
|
Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.5 | $4.0M | NEW | 170k | 23.65 |
|
Matador Resources (MTDR) | 0.5 | $4.0M | NEW | 60k | 66.77 |
|
Arcutis Biotherapeutics (ARQT) | 0.4 | $3.8M | NEW | 380k | 9.91 |
|
Roivant Sciences SHS (ROIV) | 0.4 | $3.7M | 350k | 10.54 |
|
|
SYNNEX Corporation (SNX) | 0.4 | $3.7M | NEW | 33k | 113.10 |
|
Celldex Therapeutics Com New (CLDX) | 0.4 | $3.7M | -12% | 88k | 41.97 |
|
Napco Security Systems (NSSC) | 0.4 | $3.6M | NEW | 90k | 40.16 |
|
Perella Weinberg Partners Class A Com (PWP) | 0.4 | $3.6M | NEW | 252k | 14.13 |
|
Auna S A Class A | 0.4 | $3.5M | NEW | 325k | 10.65 |
|
Essential Properties Realty reit (EPRT) | 0.4 | $3.3M | NEW | 125k | 26.66 |
|
Immunome (IMNM) | 0.4 | $3.3M | NEW | 133k | 24.68 |
|
Immunovant (IMVT) | 0.4 | $3.2M | +42% | 100k | 32.31 |
|
Atmus Filtration Technologies Ord (ATMU) | 0.4 | $3.2M | NEW | 100k | 32.25 |
|
Chewy Cl A (CHWY) | 0.4 | $3.2M | NEW | 200k | 15.91 |
|
Autolus Therapeutics Spon Ads (AUTL) | 0.4 | $3.1M | NEW | 492k | 6.38 |
|
Humacyte (HUMA) | 0.4 | $3.1M | NEW | 1.0M | 3.11 |
|
Albemarle Corp 7.25% Dep Shs A | 0.3 | $3.0M | NEW | 50k | 59.00 |
|
Absci Corp (ABSI) | 0.3 | $2.8M | NEW | 500k | 5.68 |
|
Vesta Real Estate Corp Ads (VTMX) | 0.3 | $2.7M | +27% | 70k | 39.24 |
|
Ge Healthcare Technologies I Common Stock (GEHC) | 0.3 | $2.7M | NEW | 30k | 90.91 |
|
Pagaya Technologies Cl A New | 0.3 | $2.5M | NEW | 248k | 10.10 |
|
Adc Therapeutics Sa SHS (ADCT) | 0.3 | $2.2M | NEW | 500k | 4.49 |
|
Cadre Hldgs (CDRE) | 0.3 | $2.2M | NEW | 60k | 36.20 |
|
Longboard Pharmaceuticals In (LBPH) | 0.3 | $2.2M | NEW | 100k | 21.60 |
|
Adt (ADT) | 0.3 | $2.2M | NEW | 320k | 6.72 |
|
Digitalocean Hldgs Note 12/0 (Principal) | 0.2 | $2.1M | NEW | 2.5M | 0.84 |
|
Evolus (EOLS) | 0.2 | $2.1M | NEW | 150k | 14.00 |
|
Crescent Energy Company Cl A Com (CRGY) | 0.2 | $2.1M | NEW | 175k | 11.90 |
|
Alpine Immune Sciences (ALPN) | 0.2 | $2.1M | -29% | 53k | 39.64 |
|
Eyepoint Pharmaceuticals Com New (EYPT) | 0.2 | $2.1M | -42% | 100k | 20.67 |
|
Palmer Square Capital Bdc In Com Shs | 0.2 | $2.0M | NEW | 125k | 16.29 |
|
Amer Sports Com Shs | 0.2 | $2.0M | NEW | 123k | 16.30 |
|
Terns Pharmaceuticals (TERN) | 0.2 | $2.0M | NEW | 300k | 6.56 |
|
Bilibili Spons Ads Rep Z (BILI) | 0.2 | $2.0M | NEW | 175k | 11.20 |
|
Southwest Gas Corporation (SWX) | 0.2 | $1.9M | NEW | 25k | 76.13 |
|
Pyxis Oncology Common Stock (PYXS) | 0.2 | $1.9M | NEW | 443k | 4.26 |
|
Bridgebio Pharma (BBIO) | 0.2 | $1.9M | NEW | 60k | 30.92 |
|
Spotify Usa Note 3/1 (Principal) | 0.2 | $1.8M | NEW | 2.0M | 0.92 |
|
Tarsus Pharmaceuticals (TARS) | 0.2 | $1.8M | NEW | 50k | 36.35 |
|
Regulus Therapeutics (RGLS) | 0.2 | $1.8M | NEW | 625k | 2.88 |
|
Nuveen Churchill Direct Lend Com Shs | 0.2 | $1.7M | NEW | 96k | 18.06 |
|
Dutch Bros Cl A (BROS) | 0.2 | $1.7M | NEW | 50k | 33.00 |
|
Dynatrace Com New (DT) | 0.2 | $1.6M | NEW | 35k | 46.44 |
|
Morgan Stanley Direct Lendin Com Shs | 0.2 | $1.6M | NEW | 72k | 21.55 |
|
Olema Pharmaceuticals (OLMA) | 0.2 | $1.5M | NEW | 135k | 11.32 |
|
Porch Group (PRCH) | 0.2 | $1.5M | NEW | 350k | 4.31 |
|
Meridianlink Common Stock (MLNK) | 0.2 | $1.5M | NEW | 80k | 18.70 |
|
Airbnb Note 3/1 (Principal) | 0.2 | $1.4M | NEW | 1.5M | 0.93 |
|
Mersana Therapeutics (MRSN) | 0.2 | $1.4M | NEW | 310k | 4.48 |
|
Unicycive Therapeutics (UNCY) | 0.2 | $1.4M | NEW | 1.0M | 1.38 |
|
Pepgen (PEPG) | 0.1 | $1.3M | NEW | 86k | 14.70 |
|
Praxis Precision Medicines I Com New (PRAX) | 0.1 | $1.2M | NEW | 20k | 61.02 |
|
Cardlytics (CDLX) | 0.1 | $1.1M | NEW | 75k | 14.49 |
|
Compass Therapeutics (CMPX) | 0.1 | $990k | 500k | 1.98 |
|
|
Stoke Therapeutics (STOK) | 0.1 | $912k | NEW | 68k | 13.50 |
|
NVIDIA Corporation (NVDA) | 0.1 | $904k | NEW | 1.0k | 903.56 |
|
Milestone Pharmaceuticals (MIST) | 0.1 | $895k | NEW | 500k | 1.79 |
|
Bowman Consulting Group (BWMN) | 0.1 | $870k | NEW | 25k | 34.79 |
|
Runway Growth Finance Corp (RWAY) | 0.1 | $848k | -23% | 70k | 12.12 |
|
Expedia Group Note 2/1 (Principal) | 0.1 | $731k | NEW | 790k | 0.93 |
|
Stevanato Group S P A Ord Shs (STVN) | 0.1 | $642k | NEW | 20k | 32.10 |
|
Sofi Technologies (SOFI) | 0.1 | $584k | NEW | 80k | 7.30 |
|
Five Star Bancorp (FSBC) | 0.1 | $563k | NEW | 25k | 22.50 |
|
Boundless Bio | 0.1 | $445k | NEW | 31k | 14.25 |
|
Newamsterdam Pharma Company *w Exp 99/99/999 (NAMSW) | 0.0 | $344k | NEW | 31k | 11.04 |
|
Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.0 | $340k | 369k | 0.92 |
|
|
Keurig Dr Pepper (KDP) | 0.0 | $307k | NEW | 10k | 30.67 |
|
Molecular Templates Com New (MTEM) | 0.0 | $236k | -13% | 106k | 2.24 |
|
Alight Com Cl A (ALIT) | 0.0 | $99k | NEW | 10k | 9.85 |
|
Past Filings by Monashee Investment Management
SEC 13F filings are viewable for Monashee Investment Management going back to 2015
- Monashee Investment Management 2024 Q1 filed May 14, 2024
- Monashee Investment Management 2023 Q4 filed Feb. 12, 2024
- Monashee Investment Management 2023 Q3 filed Nov. 13, 2023
- Monashee Investment Management 2023 Q2 filed Aug. 10, 2023
- Monashee Investment Management 2023 Q1 filed May 5, 2023
- Monashee Investment Management 2022 Q4 filed Feb. 9, 2023
- Monashee Investment Management 2022 Q3 filed Nov. 1, 2022
- Monashee Investment Management 2022 Q2 filed Aug. 12, 2022
- Monashee Investment Management 2022 Q1 filed May 12, 2022
- Monashee Investment Management 2021 Q4 filed Feb. 7, 2022
- Monashee Investment Management 2021 Q3 filed Nov. 9, 2021
- Monashee Investment Management 2021 Q2 filed Aug. 12, 2021
- Monashee Investment Management 2021 Q1 filed May 14, 2021
- Monashee Investment Management 2020 Q4 filed Feb. 11, 2021
- Monashee Investment Management 2020 Q3 filed Nov. 13, 2020
- Monashee Investment Management 2020 Q2 filed Aug. 11, 2020